A Wyoming man is suing Monsanto alleging the agrochemical company’s Roundup weed killer contributed to his non-Hodgkin lymphoma (NHL) diagnosis. The federal lawsuit comes just six months after Monsanto was ordered by a California jury to pay a school groundskeeper $289 million after finding his exposure to glyphosate in Roundup was the cause of his terminal NHL. (Monsanto appealed and the award was reduced to $78 million.)
The recent lawsuit involves the case of Jace Florquist, and is one of more than 8,000 filed against Monsanto alleging a link between glyphosate, the active ingredient in Roundup, and NHL. According to the lawsuit, Florquist used Roundup liberally on his property from 2008 to 2014. In July 2015, he was diagnosed with non-Hodgkin lymphoma, which he claims was caused by his exposure to glyphosate.
Florquist claims that Monsanto was aware that glyphosate was a carcinogen since the 1980s, and that the Environmental Protection Agency (EPA) had listed the chemical as a possible carcinogen but rescinded that classification under pressure by Monsanto. In 2015, the World Health Organization’s International Agency for Research on Cancer listed glyphosate as a probable carcinogen.
Monsanto denies the link. But a new analysis published in the journal Mutation Research found that individuals exposed to glyphosate had a 41 percent increased risk of developing non-Hodgkin lymphoma.
“All of the meta-analyses conducted to date, including our own, consistently report the same key finding: exposure to GBHs (glyphosate-based herbicides) are associated with an increased risk of NHL,” the authors wrote in the study.
Monsanto was acquired by Bayer AG last year.